Ya.V. VLASOV¹, M.V. CHURAKOV², R.R. BERKOVICH³, E.V. SINEOK¹

¹Samara State Medical University, 89 Chapaevskaya Str., Samara, Russian Federation, 443099

²Center for Humanitarian Technologies and Research «Social Mechanics», 67/69 Frunze Str., Samara, Russian Federation, 443099

³Multiple Sclerosis Research Center at the Neurological Department of the Medical Faculty of the Southern California University, Los Angeles, 90095, USA 

Vlasov Ya.V. ― D. Med. Sc., Professor of Neurology and Neurosurgery Department, tel. (846) 333-01-56, e-mail: sams99@inbox.ru

Churakov M.V. ― Cand. Ped. Sc., Director, tel. (846) 333-77-97, e-mail: socmech@mail.ru

Berkovich R. ― Clinical Professor, tel. +1 323 442 7551, e-mail: rberkovi@usc.edureginaberkovichmd@gmail.com

Sineok E.V. ― Cand. Med. Sc., Assistant of the Department of Ophthalmological Diseases, tel. (846) 333-01-56, e-mail: jenny.sineok@mail.ru

The article presents the results of analysis of a questionnaire survey of 442 patients with multiple sclerosis in 9 Russian regions. The study clarifies the issues for multiple sclerosis patients’ evaluation of such parameters as access to health care, screening regularity and medicine selection, availability of information about the timing of the multiple sclerosis diagnosing, appointment of timely treatment, nature of patient-physician relationship, evaluation of the appointed medication by multiple sclerosis patients.

Key words: multiple sclerosis, medical care, medical tactics, examination, treatment.

REFERENCES

1. https://www.rosminzdrav.ru/reception/stat
2. Issledovanie Fonda “Obshchestvennoe mnenie” (Opros 1500 respondentov v 53 sub»ektakh RF, iyul’ 2015 g.) [Study of the Foundation «Public Opinion» (Survey of 1500 respondents in 53 constituent entities of the Russian Federation, July 2015)].
3. Otchet “Itogi raboty Minzdrava Rossii s obrashcheniyami grazhdan v 2015g.” [The report «Results of the work of the Ministry of Health of Russia with citizens’ appeals in 2015»].
4. Issledovanie Levada Tsentr po zakazu NIU VShE (Opros 4503 respondentov v 69 sub»ektakh RF, 2014 g.) [Research Levada Center for HSE NSE (Polling 4503 respondents in 69 regions of the Russian Federation, 2014)].
5. Vlasov Ya.V., Dolgikh G.T., Dolgikh T.A. et al. Evaluation of the program of expensive drug provision using the example of therapy for multiple sclerosis with interferon. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2013, vol. 113, no. 2, iss. 2 “Rasseyannyy skleroz”, pp. 66-74 (in Russ.).
6. Otchet Instituta Upolnomochennykh Obshchestvennykh Ekspertov Obshcherossiyskoy obshchestvennoy organizatsii invalidov ― bol’nykh rasseyannym sklerozom, 2015 g. [Report of the Institute of Authorized Public Experts of the All-Russian Public Organization of Disabled People with Multiple Sclerosis, 2015].
7. Analiticheskiy otchet po rezul’tatam sotsiologicheskogo issledovaniya “Monitoring grazhdanskoy aktivnosti patsientskogo soobshchestva i resursov obshchestvennogo uchastiya v sisteme zdravookhraneniya”, pod red. N.G. Sergeevoy [Analytical report on the results of the sociological survey «Monitoring of the civil activity of the patient community and the resources of public participation in the health system». Ed. by N.G. Sergeyeva]. Samara, 2014. 96 p.
8. Kurapov M.A., Vlasov Ya.V. Pharmacotherapy of multiple sclerosis: treatment of exacerbations, immunomodulatory therapy. Farmateka, 2016, no. s4-16, pp. 24-27 (in Russ.).
9. Vlasov Ya.V., Popova E.V. Justification of the need to improve the quality of drugs used in the Russian Federation that change the course of multiple sclerosis (PITRS). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2015, no. 2, iss. 2, pp. 57-60 (in Russ.).